COLL — Collegium Pharmaceutical Share News
0.000.00%
Last trade - 00:00- $765.06m
- $1.85bn
- $780.57m
Collegium Pharmaceutical Inc expected to post a loss of 14 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Apollo Global Management, First American Financial, Thomson Reuters
U.S. RESEARCH ROUNDUP-Apollo Global Management, First American Financial, Thomson Reuters
Brief: Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
U.S. STOCKS ON THE MOVE-Sweetgreen, Zoom Video, Progyny
U.S. STOCKS ON THE MOVE-Royal Caribbean, Bed Bath & Beyond, KKR
Collegium Pharma falls after convertible debt deal launch
Brief: Collegium Pharmaceutical Announces Proposed Convertible Senior Notes Offering
Brief: Collegium Announces Fourth Quarter And Full Year 2022 Preliminary Financial Results
U.S. RESEARCH ROUNDUP- Apollo Global Management, Microsoft, ServiceNow
Brief: Collegium Provides 2023 Financial Guidance
Brief: Collegium Pharmaceutical Says Federal Circuit Upheld Judgment Of U.S. District Court For District Of Delaware Some Claims Of Patents Protecting Belbuca Are Valid
U.S. RESEARCH ROUNDUP-Altice USA, C4 Therapeutics, Lincoln National
Brief: Collegium Reports Third Quarter 2022 Financial Results
Collegium Pharmaceutical Inc reports results for the quarter ended in September - Earnings Summary
Collegium Pharmaceutical Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Collegium Reports Second Quarter 2022 Financial Results
U.S. RESEARCH ROUNDUP- Appfolio, Hyatt Hotels, TransDigm Group
Collegium Pharmaceutical Inc reports results for the quarter ended in March - Earnings Summary